BreezeBio (formerly GenEdit) is a South San Francisco genetic-medicine company developing precision-delivered nucleic acid therapies for autoimmune disease and oncology. Its proprietary NanoGalaxy platform uses non-lipid, hydrophilic polymer nanoparticles of tunable size, charge, and composition to selectively deliver DNA, RNA, and… - View it on GitHub